SLM (4000 μg) in sequential combination with axitinib is well tolerated with encouraging efficacy.
Professor of primary care and public health Azeem Majeed talks to Carla Delgado about his passion for tackling health inequalities through data As a medical…
Speaker: Gili Kenet Prof. Gili Kenet is a Pediatric Hematologist, Professor and chair of the Haematology department at the Sackler Medical School, Tel Aviv University,…
Attorneys general sued the Trump administration to block a NIH decision that would slash grant payments for research overhead
Coenzyme Q10 supplementation appears to have a beneficial effect on lipid profiles and may contribute to lowering blood pressure in patients with Type 2 Diabetes.…
The myelodysplastic syndromes (MDS) are a heterogenous group of clonal bone marrow (BM) stem cell myeloid neoplasms, characterized by BM dysplasia, macrocytic anemia or cytopenia…
“What we’ve done is create an instrument where your hands don’t need to be inside the body,” said Dr. David Wazer. “It can be done…
Small-cell lung cancer (SCLC) has limited second-line treatment options after chemotherapy. We assessed the efficacy and safety of lurbinectedin combined with pembrolizumab in relapsed SCLC…
Nicolas Sayegh , Yeonjung Jo , Umang Swami , Chadi Hage Chehade , Zeynep Irem Ozay , Georges Gebrael , Benjamin Maughan , Melissa Plets…
Giulio Francolini Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence Giulio Francolini , Vanessa Di Cataldo , Pietro Garlatti , Saverio Caini ,…
